SEC Form 4 · accession 0001437749-15-009010
HYPERION THERAPEUTICS INC · HPTX
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Christine A Nash
Officer — SVP & Chief Commercial Officer
Period of report
May 1, 2015
Accepted (ET)
May 5, 2015 · 5:35 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001386858
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | May 1, 2015 | M | 16,157 | $1.28 | A | 53,160 | D | |
| Common Stock | May 1, 2015 | M | 12,709 | $4.08 | A | 65,869 | D | |
| Common Stock | May 1, 2015 | M | 30,221 | $7.31 | A | 96,090 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Employee Stock Option (right to buy)F1 | $1.28 | May 1, 2015 | M | 16,157 | D | — | Apr 14, 2020 | Common Stock | 16,157 | 0 | D |
| Employee Stock Option (right to buy)F1 | $4.08 | May 1, 2015 | M | 12,709 | D | — | Apr 14, 2021 | Common Stock | 12,709 | 0 | D |
| Employee Stock Option (right to buy)F1 | $7.31 | May 1, 2015 | M | 30,221 | D | — | Apr 15, 2022 | Common Stock | 30,221 | 6,881 | D |
Explanation of responses
- F1This option was vested and exercisable on date of exercise.